Rezolute, Inc. (RZLT) Insider Trading & SEC Filings
Last SEC filing
Rezolute, Inc. (RZLT) has filed 3 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 2 Form 8-K material event filings were reported by RZLT in the last 90 days. InsiderAlpha tracks every RZLT SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Rezolute, Inc. (RZLT)
Rezolute, Inc. trades under the ticker RZLT. InsiderAlpha tracks 23 primary SEC Form 4 filings from 10 reporting insiders for RZLT since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001509261 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 3 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-07-07 |
Recent RZLT Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Daron Evans | CFO | F - Tax withholding / forfeiture | 3.1K | $4.99 | $15K | SEC | |
| Nevan C. Elam | CEO | F - Tax withholding / forfeiture | 8.0K | $4.99 | $40K | SEC | |
| Brian Kenneth Roberts | Chief Medical Officer | F - Tax withholding / forfeiture | 3.1K | $4.99 | $15K | SEC | |
| Daron Evans | CFO | P - Open-market purchase | 10.0K | $2.85 | $28K | SEC | |
| Nevan C. Elam | CEO | F - Tax withholding / forfeiture | 27.6K | $2.99 | $83K | SEC | |
| Brian Kenneth Roberts | Chief Medical Officer | F - Tax withholding / forfeiture | 11.4K | $2.99 | $34K | SEC | |
| Daron Evans | CFO | F - Tax withholding / forfeiture | 11.4K | $2.99 | $34K | SEC | |
| Wladimir Hogenhuis | Insider | P - Open-market purchase | 5.7K | $1.69 | $10K | SEC | |
| Brian Kenneth Roberts | Chief Medical Officer | P - Open-market purchase | 28.0K | $1.70 | $48K | SEC | |
| Daron Evans | CFO | P - Open-market purchase | 10.5K | $5.04 | $53K | SEC | |
| Gil M. Labrucherie | Insider | A - Grant or award | 21.0K | $0.00 | - | SEC | |
| Philippe Fauchet | Insider | A - Grant or award | 21.0K | $0.00 | - | SEC | |
| Young-Jin Kim | Insider | A - Grant or award | 21.0K | $0.00 | - | SEC | |
| Erik Harris | Insider | A - Grant or award | 21.0K | $0.00 | - | SEC | |
| Wladimir Hogenhuis | Insider | A - Grant or award | 21.0K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Rezolute, Inc. (RZLT). Updated in real time as new filings are submitted to the SEC.
Most-Active RZLT Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Nevan C. Elam | 1 | $40K |
| Daron Evans | 1 | $15K |
| Brian Kenneth Roberts | 1 | $15K |
Recent RZLT Form 8-K Material Events
- - Item 7.01, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 7.01, 9.01 [SEC]
- - Item 7.01, 9.01 · Clinical · neutral [SEC]
Rezolute announced results from a recent FDA meeting on March 24, 2026. The filing discloses regulatory feedback but does not specify the outcome or designation granted, making the precise impact unclear without the full press release details.
Recent Insider Filings
- - Brian Kenneth Roberts (Chief Medical Officer)
- - Nevan C. Elam (CEO)
- - Daron Evans (CFO)
- - Daron Evans (CFO)
- - Brian Kenneth Roberts (Chief Medical Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RZLT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
RZLT Insider Trading - FAQ
- What is the latest insider trade for RZLT?
- Rezolute, Inc. (RZLT) had 3 insider filings in the last 90 days, with the most recent on 2026-07-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying RZLT stock?
- 0 insider purchases of RZLT were filed in the last 90 days.
- How many insiders are selling RZLT stock?
- 0 insider sales of RZLT were filed in the last 90 days.
- Where can I see RZLT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks RZLT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $SCLX Scilex Holding Co
- $SDEV Stablecoin Development Corp
- $SEPN Septerna, Inc.
- $SHPH Shuttle Pharmaceuticals Holdings, Inc.
- $SI SHOULDER INNOVATIONS, INC.
- $SMMT Summit Therapeutics Inc.
- $SMNR Semnur Pharmaceuticals, Inc.
- $SNDA SONIDA SENIOR LIVING, INC.
- $SNYR Synergy CHC Corp.
- $SRRK Scholar Rock Holding Corp
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live RZLT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.